blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3269394

EP3269394 - MACROMOLECULAR DELIVERY SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.11.2021
Database last updated on 22.01.2025
FormerGrant of patent is intended
Status updated on  28.02.2021
FormerExamination is in progress
Status updated on  19.10.2019
FormerRequest for examination was made
Status updated on  15.12.2017
Most recent event   Tooltip19.11.2021Application deemed to be withdrawnpublished on 22.12.2021  [2021/51]
Applicant(s)For all designated states
University of Utah Research Foundation
615 Arapeen Drive, Suite 310
Salt Lake City, UT 84108 / US
[2018/03]
Inventor(s)01 / Wang, Dong
12769 Whisper Wind PL
Draper, UT 84020 / US
02 / Kopocek, Jindrich
1103 Alton Way
Salt Lake City, UT 84106 / US
03 / Miller, Scott C.
2693 Glenmare Street
Salt Lake City, UT 84106 / US
04 / Kopecková, Pavla
1103 South Alton Way
Salt Lake City, UT 84108 / US
[N/P]
Former [2018/03]01 / Wang, Dong
12769 Whisper Wind PL
Draper, UT Utah 84020 / US
02 / Kopocek, Jindrich
1103 Alton Way
Salt Lake City, UT Utah 84106 / US
03 / Miller, Scott C.
2693 Glenmare Street
Salt Lake City, UT Utah 84106 / US
04 / Kopecková, Pavla
1103 South Alton Way
Salt Lake City, UT Utah 84108 / US
Representative(s)V.O.
P.O. Box 87930
Carnegieplein 5
2508 DH Den Haag / NL
[2018/03]
Application number, filing date17188335.830.03.2005
[2018/03]
Priority number, dateUS20040558047P31.03.2004         Original published format: US 558047 P
[2018/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3269394
Date:17.01.2018
Language:EN
[2018/03]
Search report(s)(Supplementary) European search report - dispatched on:EP24.11.2017
ClassificationIPC:A61K47/58, A61K49/00, A61K49/12, A61P29/00, A61K9/14, A61K9/20, A61K9/22, A61K9/48, A61K9/52, A61K9/66, A61K9/70, A61F2/00
[2018/03]
CPC:
A61K49/0054 (EP,US); A61K47/58 (EP,US); A61K49/0041 (EP,US);
A61K49/128 (EP,US); A61P29/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/03]
TitleGerman:MAKROMOLEKULARE ABGABESYSTEME ZUR NICHTINVASIVEN DARSTELLUNG, BEURTEILUNG UND BEHANDLUNG VON ARTHRITIS UND ANDEREN ENTZÜNDLICHEN ERKRANKUNGEN[2018/03]
English:MACROMOLECULAR DELIVERY SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES[2018/03]
French:SYSTÈMES D'ADMINISTRATION MACROMOLÉCULAIRES DESTINÉS À L'IMAGERIE NON INVASIVE, L'ÉVALUATION ET LE TRAITEMENT DE L'ARTHRITE ET D'AUTRES MALADIES INFLAMMATOIRES[2018/03]
Examination procedure29.08.2017Examination requested  [2018/03]
29.08.2017Date on which the examining division has become responsible
26.10.2018Amendment by applicant (claims and/or description)
23.10.2019Despatch of a communication from the examining division (Time limit: M06)
27.03.2020Reply to a communication from the examining division
01.03.2021Communication of intention to grant the patent
13.07.2021Application deemed to be withdrawn, date of legal effect  [2021/51]
04.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2021/51]
Parent application(s)   TooltipEP05732710.8  / EP1737428
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.10.2018Request for further processing filed
26.10.2018Full payment received (date of receipt of payment)
Request granted
08.11.2018Decision despatched
The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
26.10.2018Request for further processing filed
26.10.2018Full payment received (date of receipt of payment)
Request granted
08.11.2018Decision despatched
Fees paidRenewal fee
29.08.2017Renewal fee patent year 03
29.08.2017Renewal fee patent year 04
29.08.2017Renewal fee patent year 05
29.08.2017Renewal fee patent year 06
29.08.2017Renewal fee patent year 07
29.08.2017Renewal fee patent year 08
29.08.2017Renewal fee patent year 09
29.08.2017Renewal fee patent year 10
29.08.2017Renewal fee patent year 11
29.08.2017Renewal fee patent year 12
29.08.2017Renewal fee patent year 13
28.02.2018Renewal fee patent year 14
19.03.2019Renewal fee patent year 15
28.02.2020Renewal fee patent year 16
Penalty fee
Additional fee for renewal fee
31.03.202117   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XYI]EP0331471  (SELCH LARSEN CLAUS [DK], et al) [X] 1,6,7,9,11,18,19 * page 23, paragraph 4 - page 33, paragraph 2 * * page 2, line 45 * * page 8, line 22 - line 58 * [Y] 13 [I] 5,12,14,15;
 [XYI]  - KAKIMOTO K ET AL, "The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, (1993), vol. 94, no. 2, ISSN 0009-9104, pages 241 - 246, XP002609049 [X] 1,6,7,10,18,19 * abstract * * page 242, column 1, paragraph 4 * [Y] 13 [I] 5,12,14,15
 [XAI]  - GUPTA H ET AL, "INFLAMMATION: IMAGING WITH METHOXY POLY(ETHYLENE GLYCOL)-POLY-L-LYSINE-DTPA, A LONG-CIRUCLATING GRAFT COPOLYMER", RADIOLOGY, RADIOLOGICAL SOCIETY OF NORTH AMERICA, OAK BROOK,IL, US, (19951201), vol. 197, no. 3, ISSN 0033-8419, pages 665 - 669, XP002037429 [X] 2,4,7,8,21-23 * abstract * * figures 1-4 * * page 669, column 1, paragraph 2 * * page 665, column 3, paragraph 2 * [A] 20,24 [I] 3,5,9,10,14,15,18
 [XD]  - TIMOFEEVSKI S L ET AL, "Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity", PHARMACEUTICAL RESEARCH 1996 US LNKD- DOI:10.1023/A:1016069315423, (1996), vol. 13, no. 3, ISSN 0724-8741, pages 476 - 480, XP002609050 [XD] 1,9,11,17,18 * abstract * * page 477, column 2, paragraph 4 *

DOI:   http://dx.doi.org/10.1023/A:1016069315423
 [X]  - WANG L F ET AL, "pH sensitive polymeric prodrugs containing ibuprofen, ketoprofen and naproxen as pendent groups", JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, SAGE, US, (19990101), vol. 14, no. 5, ISSN 0883-9115, pages 415 - 428, XP002184407 [X] 1,9,17,18 * abstract * * scheme 1 * * page 424, line 3 - line 10 *
    [XDAY] - WANG D ET AL, "Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems", BIOCONJUGATE CHEMISTRY 200309 US LNKD- DOI:10.1021/BC034090J, (200309), vol. 14, no. 5, ISSN 1043-1802, pages 853 - 859, XP002609051 [XD] 2,3,5,7,8,10,12,13,15-17,21 * abstract * * scheme 2 and 3 * * page 858, column 1, paragraph 3 * [A] 20,22-24 [Y] 13

DOI:   http://dx.doi.org/10.1021/bc034090j
by applicantUS4034040
    - BERGE et al., "Pharmaceutical Salts", J. of Pharma Sci., (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560

DOI:   http://dx.doi.org/10.1002/jps.2600660104
    - G.S. FIRESTEIN, "Etiology and Pathogenesis of Rheumatoid Arthritis", G.S. FIRESTEIN, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., W.B. Saunders Company, (19970000), page 921
    - F. C. MCDUFFIE, "Morbidity impact of rheumatoid arthritis in society", Am. J. Med., (19850000), vol. 78, doi:doi:10.1016/0002-9343(85)90237-2, pages 1 - 5, XP023308083

DOI:   http://dx.doi.org/10.1016/0002-9343(85)90237-2
    - J. S. SMOLEN; G. STEINER, "Therapeutic strategies for rheumatoid arthritis", Nature Review Drug Discovery, (20030000), vol. 2, pages 473 - 488
    - W. J. WALLIS; P. A. SIMKIN; W. B. NELP, "Protein traffic in human synovial effusion", Arthritis and Rheumatism, (19870000), vol. 30, pages 57 - 63
    - J. R. LEVICK, "Permeability of rheumatoid and normal human synovium to specific plasma proteins", Arthritis and Rheumatism, (19810000), vol. 24, pages 1550 - 1560
    - M. ALBUQUERQUE; J. P. DE LIMA, "Articular lymphoscintigraphy in human knees using radiolabeled dextran", Lymphology, (19900000), vol. 23, pages 215 - 218
    - L. S. WILKINSON; J. C. W., "Edwards. Demonstration of lymphatics in human synovial tissue", Rheumatol. Int., (19910000), vol. 11, pages 151 - 155
    - E. L. MATTESON, "Current treatment strategies for rheumatoid arthritis", Mayo Clin. Proc., (20000000), vol. 75, doi:doi:10.4065/75.1.69, pages 69 - 74, XP000944521

DOI:   http://dx.doi.org/10.4065/75.1.69
    - E. SANTANA-SAHAGUN; M. H. WEISMAN, "Nonsteroidal Anti-inflammatory Drugs", E. SANTANA-SAHAGUN; M. H. WEISMAN, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, W.B. Saunders Company, (19970000), pages 799 - 822
    - C. M. STEIN; T. PINCUS, "Glucocorticoids", C. M. STEIN; T. PINCUS, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., W.B. Saunders Company, (19970000), pages 823 - 840
    - J. KOPECEK; P. KOPECKOVA; T. MINKO; Z. R. LU, "HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action", Eur. J. Pharm. Biopharm., (20000000), vol. 50, doi:doi:10.1016/S0939-6411(00)00075-8, pages 61 - 81, XP004257180

DOI:   http://dx.doi.org/10.1016/S0939-6411(00)00075-8
    - L. W. SEYMOUR, "Passive tumor targeting of soluble macromoleculaes and drug conjugates", Critical Reviews In Therapeutic Drug Carrier Systems, (19920000), vol. 9, pages 135 - 187
    - J. M. METSELAAR; M. H. WAUBEN; J. P. WAGENAAR-HILBERS; O. C. BOERMAN; G. STORM, "Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes", Arthritis Rheum, (20030000), vol. 48, doi:doi:10.1002/art.11140, pages 2059 - 2066, XP002609052

DOI:   http://dx.doi.org/10.1002/art.11140
    - M. N. J. PALEY; I. D. WILKINSON; E. VAN BEEK; P. D. GRIFFITHS, "Magnetic resonance imaging: basic principles", M. N. J. PALEY; I. D. WILKINSON; E. VAN BEEK; P. D. GRIFFITHS, R. G. Grainger, D. Allison, A. Adam and A. K. Dixon, Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging, 4th ed., Churchill Livingstone, Inc, (20010000), pages 101 - 136
    - J. KOPECEK; H. BAZILOVA, "Poly[N-(2-hydroxypropyl) methacrylamide]. I. Radical polymerization and copolymerization", Eur. Polym. J., (19730000), vol. 9, doi:doi:10.1016/0014-3057(73)90063-3, pages 7 - 14, XP025863514

DOI:   http://dx.doi.org/10.1016/0014-3057(73)90063-3
    - V. OMELYANENKO; P. KOPECKOVA; C. GENTRY; J. KOPECEK, "Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate", J. Controlled Release, (19980000), vol. 53, doi:doi:10.1016/S0168-3659(97)00235-6, pages 25 - 37, XP004121254

DOI:   http://dx.doi.org/10.1016/S0168-3659(97)00235-6
    - S. MOORE; W. H. STEIN, "A modified ninhydrin reagent for the photometric determination of amino acids and related compounds", J. Biol. Chem., (19540000), vol. 211, pages 907 - 913
    - Z. R. LU; X. WANG; D. L. PARKER; K. C. GOODRICH; H. R. BUSWELL, "Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging", Bioconjug Chem., (20030000), vol. 14, doi:doi:10.1021/bc0340464, pages 715 - 719, XP002490707

DOI:   http://dx.doi.org/10.1021/bc0340464
    - A. M. BENDELE, "Animal models of rheumatoid arthritis", J. Musculoskel. Neuron. Interact., (20010000), vol. 1, pages 377 - 385
    - D. WANG; S. C. MILLER; M. SIMA; P. KOPECKOVA; J. KOPECEK, "Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems", Bioconjug. Chem., (20030000), vol. 14, doi:doi:10.1021/bc034090j, pages 853 - 859, XP002609051

DOI:   http://dx.doi.org/10.1021/bc034090j
    - I. KUSHNER; J. A. SOMERVILLE, "Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation", Arthritis and Rheumatism, (19710000), vol. 14, pages 560 - 570
    - T. P. JACOBS; O. KEMPSKI; D. MCKINLEY; A. J. DUTKA; J. M. HALLENBECK; G. FEUERSTEIN, "Blood flow and vascular permeability during motor dysfunction in a rabbit model of spinal cord ischemia", Stroke, (19920000), vol. 23, pages 367 - 373
    - Y. MATSUMURA; H. MAEDA, "A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs", Cancer Res., (19860000), vol. 46, pages 6387 - 6392, XP002084436
    - "Principles of Magnetic Resonance Imaging", M. A. BROWN; R. C. SEMELKA, MRI: Basic Principles and Applications, 3rd ed., Wiley-Liss, (20030000), pages 27 - 42
    - D. CLAVEAU; M. SIRINYAN; J. GUAY; R. GORDON; C. C. CHAN; Y. BUREAU; D. RIENDEAU; J. A. MANCINI, "Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model", J. Immunol., (20030000), vol. 170, pages 4738 - 4744, XP002356597
    - M. I. V. JAYSON; A. ST. J. DIXON, "Intra-articular pressure in the rheumatoid arthritis of knee. I. Pressure changes during passive joint distension", Ann. Rheum. Dis., (19700000), vol. 29, pages 261 - 265
    - Y. OKADA, "Proteinases and Matrix Degradation", Y. OKADA, S. Ruddy, E. D. Harris Jr. and C. B. Sledge, Kelley's Textbook of Rheumatology, 6th ed., Saunders Company, (19970000), pages 55 - 72
    - P. S. TREUHAFT; D. J. MCCARTY, "Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases", Arthritis and Rheumatism, (19710000), vol. 14, pages 475 - 484
    - I. GIRAUD; M. RAPP; J. C. MAURIZIS; J. C. MADELMONT, "Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of 14 C-labeled quaternary ammonium-glucosamine conjugates", Bioconjug. Chem., (20000000), vol. 11, doi:doi:10.1021/BC990128+, pages 212 - 218, XP002611626

DOI:   http://dx.doi.org/10.1021/BC990128+
    - M. RAPP; GIRAUD I.; MAURIZIS J.C.; GALMIER M.J.; MADELMONT J.C., "Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug", Bioconjug Chem., (20030000), vol. 14, no. 2, doi:doi:10.1021/bc020031e, pages 500 - 6, XP055030105

DOI:   http://dx.doi.org/10.1021/bc020031e
    - A. WUNDER; MULLER-LADNER U.; STELZER E.H.; FUNK J.; NEUMANN E.; STEHLE G.; PAP T.; SINN H.; GAY S.; FIEHN C, "Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis", J. Immunol., (20030000), vol. 170, no. 9, pages 4793 - 801, XP002371816
    - S. L. TIMOFEEVSKI; PANARIN E.F.; VINOGRADOV O.L.; NEZHENTSEV M.V., "Anti-inflammatory and antishock water-soluble polyesters of glucocorticoids with low level systemic toxicity", Pharm Res., (19960000), vol. 13, no. 3, doi:doi:10.1023/A:1016069315423, pages 476 - 80, XP002609050

DOI:   http://dx.doi.org/10.1023/A:1016069315423
    - H. KITAMURA; KATO A.; ESAKI T, "AG-041R, a novel indoline-2-one derivative, induces systemic cartilage hyperplasia in rats", Eur J. Pharmacol., (20010000), vol. 418, no. 3, pages 225 - 30
    - F. DEMSAR; VAN DIJKE C.F.; KIRK B.A.; KAPILA S.; PETERFY C.G.; ROBERTS T.P.; SHAMES D.M.; TOMAZIC S.; MANN J.; BRASCH R.C., "Mapping abnormal synovial vascular permeability in temporomandibular joint arthritis in the rabbit using MRI", Br. J. Rheumatol., (19960000), vol. 35, no. 3, pages 23 - 25
    - P. B. JACOBSON; MORGAN S.J.; WILCOX D.M.; NGUYEN P.; RATAJCZAK C.A.; CARLSON R.P.; HARRIS R.R., "Nuss M. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat", Arthritis Rheum., (19990000), vol. 42, no. 10, pages 2060 - 73
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.